TEVIMBRA (tislelizumab-jsgr)

**Product type:** Human Prescription Drug

**Active ingredient:** TISLELIZUMAB

**Strength:** 10 mg/mL

**Dosage form:** Injection, Solution, Concentrate

**Route:** Intravenous

**Labeler:** BeOne Medicines USA, Inc.

**Marketing category:** BLA (BLA761232)

**Pharmacologic class:** Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]